Skip to main content

Table 1 Baseline characteristics of GHD subjects and controls. Values are displayed as median and (interquartile range)

From: The modulation of platelet function by growth hormone in growth hormone deficient Hypopituitary patients

Measurement

GHD (n = 13, M = 7)

Controls (n = 13, M = 7)

P value

Age(years)

47(38.5–55.5)

52(43.5–64.5)

0.2

IGF-1(ng/ml)

127.8(101.9-132.25)

180.7(171.8–196)

0.004**

Free T4(pmol/l)

9.3(8.15–12.35)

10.7(9.95–11.95)

0.42

Haemaglobin(g/dL)

13.8(12.2-14.15)

13.5(12.6–15.8)

0.31

Platelet count(109 /L)

261(222–282)

234(194–305)

0.59

WCC(109 /L)

6.97(5.43–8.92)

4.48(3.85–7.58)

0.04*

INR

1.0(0.96-1.0)

1.05(1.0-1.08)

0.57

Creatinine(umol/l)

75(62–83)

69(52.5–74)

0.18

Total cholesterol(mmol/l)

5.39(4.48–6.76)

5.44(3.56–5.78)

0.54

LDL-C(mmol/l)

3.11(2.46–4.63)

2.63(1.32–3.84)

0.29

HDL-C(mmol/l)

1.35(0.98–1.72)

1.37(0.84–1.59)

0.68

Triglycerides(mmol/l)

1.38(1.13–1.58)

0.97(0.85–1.81)

0.2

Fasting glucose(mmol/l)

4.8(4.5–5.25)

5.3(4.85–6.25)

0.06

Testosterone(males,nmol/l)

19.5(16.9–22.5)

16.3(10.2–20.7)

0.25

HbA1C(DCCT)

5.4(5.4–5.6)

5.5(5.15–6.4)

0.59

Fasting Insulin(mIU/L)

5.6(2.9–9.55)

8(3.5-12.25)

0.40

Albumin(g/L)

44(41.25–45.75)

43(39.5–46)

0.69

  1. Insulin-like growth factor I (IGF-1), thyroid-stimulating hormone (TSH), white cell count, (WCC), international normalised ratio (INR), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), Glycated haemoglobin (HbA1C)
  2. Values are displayed as median (Interquartile range). A Mann Whitney u-test was used to assess for statistically significant differences at baseline between the GHD group and controls. Values were considered statistically significant where p < 0.05*, < 0.01**, < 0.00